C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof

Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
01/2002
01/02/2002	EP0785938B1 Fused pyrrolocarbazoles
01/02/2002	CN1329671A Non-homogeneous systems for resolution of enantiomeric mixtures
01/02/2002	CN1329618A Nucleosides with anti-hepatitis B virus activity
01/01/2002	US6335439 Method of preparing phosphoramidites
01/01/2002	US6335432 For fluorescent hybridization probes for use in diagnosis, research, and therapy
01/01/2002	US6335322 Therapeutic agents
12/2001
12/27/2001	WO2001034614A3 Compositions and methods for double-targeting virus infections and targeting cancer cells
12/26/2001	CN1328457A Use of N-substituted-1,5-dideoxy -1,5-imino-D-glucitol compounds for treating hepatitis virus
12/25/2001	US6333315 4′-C-ethynyl purine nucleoside compounds
12/25/2001	US6333153 Modifying duplex dna by mixing the mismatch duplex dna with a muts homolog dimer in the presence of a binding solution which contains adenosine triphosphate nucleotides at a concentration of less than 3 micromolar
12/25/2001	CA2234164C Novel orthosomycins from micromonospora carbonacea
12/25/2001	CA2027023C Inosine/guanosine derivatives
12/20/2001	WO2001096609A1 Method for screening dna binding
12/20/2001	WO2001096357A2 Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
12/20/2001	WO2001096356A1 Antisense molecules and method of controlling expression of gene function by using the same
12/20/2001	WO2001096355A1 Nucleoside derivatives
12/20/2001	WO2001096354A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues
12/20/2001	WO2001096353A2 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES
12/20/2001	US20010053763 Method and composition for modulating an immune response
12/20/2001	US20010053519 Nucleotide sequences for use as tool in genetic engineering
12/20/2001	DE10024308C1 Purification of 3'-phosphoadenosine-5'-phosphosulfate, for use in determination of sulfotransferase activity, comprises ion exchange chromatography on a supported, functionalized acrylamide hydrogel
12/20/2001	CA2411036A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues
12/19/2001	EP1164138A1 Terpyridine-platinum (II) complexes
12/19/2001	EP1163251A1 N-acylphosphoramidites and their use in oligonucleotide synthesis
12/19/2001	EP1163250A2 Improved synthesis of [2.2.1]bicyclo nucleosides
12/19/2001	EP0971717B1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
12/18/2001	US6331398 Nucleic acid ligands
12/18/2001	US6331287 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside
12/13/2001	WO2001094609A1 Charge-switch nucleotides
12/13/2001	WO2001094368A1 2-aminocarbonyl-9h-purine derivatives
12/13/2001	WO2001093905A1 Immunostimulatory oligodeoxynucleotides
12/13/2001	WO2001093903A1 Antigenic composition comprising a polycationic peptide and inosine and cytosine
12/13/2001	WO2001093873A1 Use of aicar and related compounds
12/13/2001	WO2001040243A3 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
12/13/2001	WO2000030656A9 Neuron stimulation by ribavirin, and analogs thereof
12/13/2001	US20010051612 Vasodilation; using 2-adenosine propargyl phenyl ether
12/13/2001	US20010051340 Assay for the detection of preferential particles
12/13/2001	CA2412567A1 Charge-switch nucleotides
12/13/2001	CA2411575A1 Immunostimulatory oligodeoxynucleotides
12/12/2001	EP1161681A2 Use of lna in mass spectrometry
12/12/2001	EP1161439A1 Xylo-lna analogues
12/12/2001	EP0906327B1 Intermediates for oligonucleotide synthesis
12/12/2001	EP0589964B1 Method and composition to reduce myocardial reperfusion injury
12/12/2001	CN1076021C L-2',3'-dideoxy nucleoside analogs as antihepatitis B (HBV) and anti-HIV agents
12/11/2001	US6329519 Intermediates for oligonucleotide synthesis
12/11/2001	US6329515 Includes bivalent metal cation, trivalent metal cation, and biomaterial such as nucleoside-5'-monophosphate, nucleoside-5'-triphosphate, dna or rna
12/11/2001	US6329350 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
12/11/2001	US6329346 Oligo-2′-deoxynucleotides and their use as pharmaceutical agents with antiviral activity
12/11/2001	US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating
12/11/2001	CA2024919C Process for the preparation of 23-(c1-c6 alkyloxime)-ll-f28249 compounds
12/09/2001	CA2311084A1 C8-substituted purine nucleotide analogs and their use as inhibitors of nucleoside triphosphate diphosphohydrolases
12/06/2001	WO2001092284A1 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
12/06/2001	WO2001092282A2 Methods and compositions for treating flaviviruses and pestiviruses
12/06/2001	WO2001091737A2 Methods for treating hepatitis delta virus infection with beta-l-2' deoxy-nucleosides
12/06/2001	WO2001066118A8 4'-thio-l-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof
12/06/2001	WO2001020035A3 Methods and compositions for linear isothermal amplification of polynucleotide sequences
12/06/2001	WO2000077018A3 Purine derivatives
12/06/2001	US20010049372 Antiviral nucleoside analogues
12/06/2001	US20010049109 Comprising a donor dye having a specified absorption maxima, and an acceptor dye capable of absorbing excitation energy emitted by the donor dye and emitting light in response of given emission maxima
12/06/2001	US20010049105 Electrophoretic tag (e-tag) probes; detection involves the release of identifying tags as a consequence of target recognition
12/06/2001	CA2408143A1 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
12/05/2001	EP1159282A1 Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
12/05/2001	EP1158995A1 Biologically active compounds of ganoderma pfeifferi dms 13239
12/05/2001	CN1324800A Prepn. of 2',3'-didehydro-3'-deoxythymidine
12/04/2001	US6326491 Process to prepare pyrimidine nucleosides
12/04/2001	US6326490 Antiproliferation agents or anticarcinogenic agents
12/04/2001	US6326370 Use of agonists or antagonists of P2 purinoceptors for the prevention of glutamate-evoked cytotoxicity
12/04/2001	US6326359 Adenosine A2A receptor agonists as antiinflammatory agents
12/04/2001	US6326199 Hybridization and rnace activation in a cell with oligonucleotides
12/04/2001	US6326173 Amplification of target nucleic acids; join nucleic acid to chip, hybridize to primer, incubate with enzymes, amplify, recover amplification products
12/04/2001	US6326153 Polynucleotide sequencing
12/04/2001	CA2278883C Very large scale immobilized peptide synthesis
12/04/2001	CA2024253C Entities for cancer therapy
11/2001
11/29/2001	WO2001090130A1 Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
11/29/2001	WO2001090121A2 Methods and compositions for treating hepatitis c virus
11/29/2001	WO2001060835A8 Purine derivatives
11/29/2001	US20010046676 Integrated sequencing device
11/29/2001	CA2712547A1 Methods and compositions for treating hepatitis c virus
11/28/2001	EP1157698A2 Treatment of inflammatory diseases with oxypurine nucleosides
11/28/2001	EP0630898B1 Thrombocytopenia remedy
11/27/2001	US6323339 Glycosylating substrate in presence of lewis acid; purification; combinatorial chemistry
11/27/2001	US6323187 Therapeutic dinucleotide and derivatives
11/27/2001	US6323186 Phosphate-bound polyazaindacene derivatives of nucleotides
11/27/2001	US6322987 Carbamate-derivatized nucleosides and oligonucleosides
11/27/2001	US6322980 Single nucleotide detection using degradation of a fluorescent sequence
11/27/2001	US6322771 Parenterally administering to a mammal a purine derivative to diagnose coronary artery stenosis
11/27/2001	CA2045864C Stable salts of 4"-deoxy-4" epi-methylamino avermectin bla/blb
11/22/2001	WO2001087913A2 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001	WO2001087235A2 Method for producing[18f]fluoride ion
11/22/2001	US20010044531 For probes, comprising a heterocycle condensed with a cyclic group such as ribofuranose derivative; biotin and 5-carboxyfluorescein derivatives
11/22/2001	US20010044530 Producing immobilized oligonucleotides on a substrate by covalently attaching a first nucleotide or oligonucleotide via a C-5' oxygen of the nucleotide to the substrate; C-3'oxygen protected with photo- or chemical-labile groups
11/22/2001	US20010044529 Deprotecting an oligonucleotide by heating in a fluid, where the phosphorus atom is O-protected with a thermolabile group such as (pyrrolidin-1-one-1-yl)alkyl; synthesis of oligonucleotides
11/22/2001	CA2408842A1 Method for treating retinal degeneration with purinergic receptor agonists
11/21/2001	EP1155695A1 1,3 oxathiolane nucleoside analogues
11/21/2001	EP1155140A1 Methods for making morpholino-nucleotides, and their use for analysing and marking nucleic acid sequences
11/21/2001	EP1155027A2 Synthesis of labelled oligonucleotides on solid-supports
11/21/2001	CN1074924C Preparing method for medical composition containing 1,3-oxathiolane nucleoside analogues
11/20/2001	US6320044 Process for recovering lipophilic oligosaccharide antibiotics
11/20/2001	US6320041 Pre-activated carbonyl linkers for the modification of oligonucleotides
11/20/2001	US6320040 Preparing novel nucleoside oligomers bearing pendant conjugate groups for incorporation into nucleic acids

1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 201